Jerusalem, Israel

Joseph Tam

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Joseph Tam: Innovator in Cannabinoid Research

Introduction

Joseph Tam is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of cannabinoid research, holding a total of 4 patents. His work focuses on developing novel therapeutic compounds that have the potential to impact various medical applications.

Latest Patents

Among his latest patents, Joseph Tam has developed CB1R receptor blockers with acyclic backbones. This invention concerns a novel class of CB1 receptor binding molecules and their uses. Another significant patent is for cannabinoid acid ester compositions and their uses. This disclosure provides pharmaceutical compositions that include a cannabinoid acid ester compound, either alone or in combination with additional cannabinoid compounds. The cannabinoid acid ester compound may be a cannabidiolic acid ester, and the patent outlines various therapeutic applications, including combination therapies using these compounds.

Career Highlights

Joseph Tam has worked with esteemed organizations such as Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and the University of Guelph. His career reflects a commitment to advancing cannabinoid research and its applications in medicine.

Collaborations

Throughout his career, Joseph has collaborated with prominent figures in the field, including Raphael Mechoulam and Reem Smoum. These collaborations have further enriched his research and innovations.

Conclusion

Joseph Tam's contributions to cannabinoid research and his innovative patents highlight his role as a leading inventor in this field. His work continues to pave the way for new therapeutic possibilities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…